You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽隆藥業(002898.SZ):獲得門冬氨酸鳥氨酸注射液藥品註冊批件
格隆匯 05-13 19:31

格隆匯5月13日丨賽隆藥業(002898.SZ)公佈,公司全資子公司湖南賽隆藥業有限公司於近日獲得國家藥品監督管理局核准簽發的門冬氨酸鳥氨酸注射液《藥品註冊批件》。

門冬氨酸鳥氨注射適用因急、慢性肝病(如各型肝炎、肝硬化脂肪肝、肝炎後綜合症)引發的血氨升高及治療肝性腦病,如伴發或繼發於肝解毒功能受損(如肝硬化)的潛在性或發作期肝性腦病,尤其適用於治療肝昏早期或肝昏迷期的意識模糊狀態

上述藥品的獲批生產並上市銷售將對公司業績產生積極的影響,具體銷售情況則取決於內外部環境變化等多種因素,存在一定的不確定性,公司將及時根據後續進展履行信息披露義務,敬請廣大投資者謹慎決策,注意防範投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account